Patients infected with Fasciola gigantica may experience a range of symptoms, which can vary depending on the stage of the infection. In the early, or acute, phase, symptoms may include fever, abdominal pain, nausea, and vomiting. As the infection progresses to the chronic phase, symptoms may include jaundice (yellowing of the skin and eyes), weight loss, and anemia. The chronic phase is characterized by the parasite's presence in the bile ducts, leading to inflammation and obstruction.

Diagnosing fascioliasis caused by Fasciola gigantica involves a combination of clinical evaluation, laboratory tests, and imaging studies. Blood tests may reveal elevated levels of eosinophils, a type of white blood cell that increases in response to parasitic infections. Serological tests can detect antibodies against the parasite. Imaging studies, such as ultrasound or CT scans, can help visualize liver damage and the presence of the parasite in the bile ducts. Stool samples may also be examined for the presence of parasite eggs, although this is more common in the chronic phase.

The primary treatment for fascioliasis is the antiparasitic medication triclabendazole, which is effective against both the immature and adult stages of Fasciola gigantica. The drug is usually administered in a single or double dose, depending on the severity of the infection. In cases where triclabendazole is not available or effective, other medications such as nitazoxanide may be considered. Supportive care, including pain management and treatment of secondary infections, may also be necessary.

With timely and appropriate treatment, the prognosis for fascioliasis caused by Fasciola gigantica is generally good. Most patients respond well to triclabendazole, and symptoms typically resolve within a few weeks. However, if left untreated, the infection can lead to severe complications, including liver damage, bile duct obstruction, and secondary bacterial infections. Chronic infections may result in long-term health issues, such as cirrhosis or liver failure.

Fasciola gigantica is transmitted to humans through the ingestion of contaminated water or plants, particularly watercress and other aquatic vegetation. The parasite's life cycle involves freshwater snails as intermediate hosts. Humans become infected when they consume the metacercariae, the infective stage of the parasite, which encyst on aquatic plants. Once ingested, the metacercariae excyst in the intestine and migrate to the liver, where they mature into adult flukes.

Fasciola gigantica is predominantly found in tropical and subtropical regions, including parts of Africa, Asia, and the Middle East. The disease is more common in rural areas where people rely on untreated water sources and consume raw or undercooked aquatic plants. Livestock, such as cattle and sheep, are also commonly infected, serving as a reservoir for the parasite. Human cases are often associated with agricultural activities and poor sanitation.

The pathophysiology of fascioliasis involves the migration and maturation of Fasciola gigantica within the host's body. After ingestion, the metacercariae excyst in the duodenum and penetrate the intestinal wall. They then migrate through the peritoneal cavity to the liver, where they mature into adult flukes. The adult flukes reside in the bile ducts, causing inflammation, obstruction, and damage to liver tissue. The immune response to the parasite can also contribute to tissue damage and symptoms.

Preventing fascioliasis involves measures to reduce exposure to the parasite. This includes avoiding the consumption of raw or undercooked aquatic plants, particularly in endemic areas. Ensuring access to clean and safe drinking water is crucial. Public health initiatives aimed at controlling the snail population, such as environmental management and the use of molluscicides, can also help reduce transmission. Educating communities about the risks and transmission routes of the disease is essential for prevention.

Fasciola gigantica is a parasitic liver fluke that causes fascioliasis, a disease affecting the liver and bile ducts. It is prevalent in tropical and subtropical regions and is transmitted through contaminated water and plants. Symptoms range from fever and abdominal pain to jaundice and weight loss. Diagnosis involves clinical evaluation, laboratory tests, and imaging studies. Treatment with triclabendazole is effective, and prevention focuses on reducing exposure to the parasite.

Fasciola gigantica is a parasite that can infect the liver, causing a disease called fascioliasis. It is common in warmer climates and is spread through contaminated water and plants. Symptoms can include fever, stomach pain, and yellowing of the skin. Doctors can diagnose the infection with blood tests and scans, and it is usually treated with medication. To prevent infection, avoid eating raw water plants and drink clean water.